Scientific exchange · Dr. Quentin Ueda

13 Jun 2026 · Virtual · Dr. Quentin Ueda, Guy's and St Thomas' · MSL Dr. Anna Becker · Nephrada

ReviewedManualENG-0163—

Capture insight from this engagement

Location: Guy's and St Thomas'
Therapeutic area: Nephrology
Country: United Kingdom
Stakeholder tier: Tier 1
Strategic objective: Not linked
Initiative: Not linked
MSL: ABDr. Anna BeckerMSL, Nephrology (DACH)
Product: Nephrada (nephradin)

Topics discussed

Treatment burden and fatigue
Proteinuria as surrogate endpoint
APRIL pathway mechanism

Scientific content used

NPH mechanism-of-action deck

Questions raised

Is there any data on APRIL inhibition in FSGS?

Notes

Scientific exchange with academic nephrologist at Guy's and St Thomas'. Discussed treatment burden and fatigue, proteinuria as surrogate endpoint, april pathway mechanism.

Insights captured (0)

Capture insight

No insights captured from this engagement.

Review workflow

Draft
Submitted
3Reviewed

Review complete. Quality ratings and insights can now be used in aggregates.

Follow-ups

Send publication reprint

0 of 1 complete

Quality ratings

1–5, rated at review

Scientific relevance: 3
Strategic relevance: 2
Depth of exchange: 4
Actionability: 4

Data lineage

Source system: Manual
Sync: Entered manually in Hub
System of record: Hub
Record id: ENG-0163

Audit history (0)

All create, update and approval events for this record

No audit events in sample data